Dr. Anderson on current and future treatment for multiple myeloma | Dana-Farber Cancer Institute

Kenneth Anderson, MD, envisions the future of multiple myeloma treatment with novel therapies, including proteasome inhibitors and immunomodulatory drugs, as well as therapies for smoldering disease. Learn more about the Multiple Myeloma Program at Dana-Farber. https://www.dana-farber.org/multiple-myeloma-program/
View more presentations from the 2017 Multiple Myeloma patient Education Symposium at Dana-Farber Cancer Institute. http://www.dana-farber.org/health-library/videos/multiple-myeloma-patient-symposium-video-presentations/